GMP BIOMANUFACTURING SERVICES
ABL has a long and successful history providing contract development and GMP biomanufacturing services to the biopharmaceutical industry. With a primary focus on viral vectors, ABL operates GMP facilities in the USA and Europe to meet your global regulatory and redundancy requirements.
ABL offers a comprehensive, phase-specific portfolio of services for the prompt and effective development, manufacture and testing of viral vectors used in your gene therapy, oncolytic, and vaccine candidates.
YEARS OF EXPERIENCE
ABL draws on decades of experience developing and producing hundreds of GMP batches to deliver your product in a timely and cost-effective manner. From process development to cell banking to production of bulk drug substance and aseptic fill finish, ABL supports a diverse range of viral vectors (AAV, Adenovirus, HSV, Vaccinia, and others) and proteins (Monoclonal Antibodies, Fusion Proteins, Glycoproteins, and more).
Focus on your strengths! Here at ABL, we develop and produce advanced therapies utilizing our extensive experience, multi-decade track record and our clients’ need for demonstrated expertise.
ABL’s U.S. location adheres to Good Manufacturing Practice (GMP) standards and is ISO 9001 accredited. ABL Europe’s facilities are regularly inspected by the French regulatory authorities (ANSM) and is a GMP licensed site for the manufacture of drug substance and aseptically prepared small volume liquid (drug product) viral products in accordance with EMA regulations.